文献速递眼底病与葡萄膜炎

MRTF-A抑制剂抑制视网膜色素上皮细胞上皮-间质转化

Suppression of Epithelial-Mesenchymal Transition in Retinal Pigment Epithelial Cells by an MRTF-A Inhibitor.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2019-01-01

本研究探讨心肌素相关转录因子A(MRTF-A)在视网膜色素上皮(RPE)细胞上皮-间质转化(EMT)及视网膜下纤维化中的作用,采用细胞划痕实验、免疫荧光、免疫印迹、逆转录定量PCR和明胶酶谱等方法。结果显示MRTF-A信号抑制剂CCG-1423以浓度依赖方式抑制RPE-1细胞迁移,并减轻TGF-β2诱导的相关蛋白与mRNA上调;玻璃体腔注射CCG-1423可明显减轻小鼠光凝诱导的视网膜下纤维化。

要点

  • MRTF-A抑制剂CCG-1423以浓度依赖方式抑制RPE-1细胞迁移。
  • CCG-1423减轻TGF-β2诱导的α-SMA、桩蛋白、pro-MMP-2蛋白及α-SMA、COL1、CTGF mRNA上调。
  • 玻璃体腔注射CCG-1423可明显减轻小鼠光凝诱导的视网膜下纤维化。

核心结论

  • MRTF-A参与RPE细胞EMT及体内视网膜下纤维化发展,是视网膜下纤维化相关视网膜疾病的潜在治疗靶点。

研究设计与样本

  • 研究在培养的人RPE-1细胞中采用划痕实验评估迁移活性。
  • 用免疫荧光分析RPE-1细胞中MRTF-A的亚细胞分布及小鼠模型中视网膜下纤维化程度。
  • 用免疫印迹或逆转录定量PCR检测α-SMA、COL1、CTGF和桩蛋白表达,用明胶酶谱评估pro-MMP-2。
  • 体内采用光凝诱导的小鼠视网膜下纤维化模型,行玻璃体腔注射CCG-1423。

主要发现

  • MRTF-A信号抑制剂CCG-1423以浓度依赖方式抑制RPE-1细胞迁移。
  • TGF-β2诱导MRTF-A从RPE-1细胞胞质转位至细胞核,该效应被CCG-1423减弱。
  • TGF-β2上调α-SMA、桩蛋白和pro-MMP-2蛋白及α-SMA、COL1和CTGF mRNA,且该上调对CCG-1423抑制敏感。
  • 玻璃体腔注射CCG-1423明显减轻光凝诱导的体内视网膜下纤维化发展。

临床怎么用

  • 结果提示MRTF-A可作为以视网膜下纤维化为特征的视网膜疾病的潜在治疗靶点,CCG-1423为相关候选抑制剂。

局限性

  • 研究为细胞实验与小鼠模型,尚未提供人体临床数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Epithelial-mesenchymal transition (EMT) in retinal pigment epithelial (RPE) cells is related to the pathogenesis of subretinal fibrosis such as that associated with macular degeneration. The role of myocardin-related transcription factor A (MRTF-A) in EMT of RPE cells and subretinal fibrosis was investigated. METHODS: The migratory activity of human RPE-1 cells in culture was evaluated using a scratch assay. The subcellular distribution of MRTF-A in RPE-1 cells, as well as the extent of subretinal fibrosis in a mouse model, were determined by immunofluorescence analysis. Expression of α-smooth muscle actin (α-SMA), collagen type I (COL1), connective tissue growth factor (CTGF), and paxillin was examined by immunoblot analysis or reverse transcription and quantitative polymerase chain reaction analysis, whereas that of pro-matrix metalloproteinase-2 (MMP-2) was assessed by gelatin zymography. RESULTS: The MRTF-A signaling inhibitor CCG-1423 suppressed RPE-1 cell migration in a concentration-dependent manner. Transforming growth factor-beta (TGF-β2) induced MRTF-A translocation from the cytoplasm to the nucleus of RPE-1 cells, and this effect was attenuated by CCG-1423. TGF-β2 up-regulated the abundance of α-SMA, paxillin, and pro-MMP-2 proteins as well as the amounts of α-SMA, COL1, and CTGF mRNAs in a manner sensitive to inhibition by CCG-1423. Finally, intravitreal injection of CCG-1423 markedly attenuated the development of subretinal fibrosis induced by photocoagulation in vivo. CONCLUSIONS: Our results implicate MRTF-A in EMT of RPE cells and in the development of subretinal fibrosis in vivo, suggesting that MRTF-A is a potential therapeutic target for retinal diseases characterized by subretinal fibrosis.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Kobayashi M, Tokuda K, Kobayashi Y, et al. Suppression of Epithelial-Mesenchymal Transition in Retinal Pigment Epithelial Cells by an MRTF-A Inhibitor. Invest Ophthalmol Vis Sci. 2019. PMID: 30707754. doi:10.1167/iovs.18-25678

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。